Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.3050
+0.055022.00%
Pre-market: 0.2830-0.0220-7.21%05:02 EDT
Volume:6.76M
Turnover:1.95M
Market Cap:78.46M
PE:-1.02
High:0.3224
Open:0.2530
Low:0.2449
Close:0.2500
Loading ...

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Adaptimmune Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Adaptimmune Therapeutics Plc : H.c. Wainwright Cuts Target Price to $3 From $3.5

THOMSON REUTERS
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live
·
28 Mar

Barclays Remains a Sell on Adaptimmune Therapeutics (ADAP)

TIPRANKS
·
27 Mar

Adaptimmune Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
26 Mar

Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $1.75 From $3

THOMSON REUTERS
·
26 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

Adaptimmune Therapeutics (ADAP) Gets a Buy from Scotiabank

TIPRANKS
·
25 Mar

ADAP 4Q24 Earnings Review: EPS Miss on 1x Restructuring/Impairment Costs; Potential Capital Raise Adds Risk to the Story

Zacks Small Cap Research
·
25 Mar

BRIEF-Adaptimmune Therapeutics PLC - Enters Amendment To Loan And Security Agreement - SEC Filing

Reuters
·
25 Mar

Adaptimmune Therapeutics Plc - to Make $25 Mln Loan Prepayment - SEC Filing

THOMSON REUTERS
·
25 Mar

Adaptimmune Therapeutics Plc : Scotiabank Cuts Target Price to $1.4 From $3.15

THOMSON REUTERS
·
21 Mar

Adaptimmune Therapeutics PLC (ADAP) (Q4 2024) Earnings Call Highlights: Strategic Growth and ...

GuruFocus.com
·
21 Mar

Adaptimmune Therapeutics (ADAP) Receives a Buy from Mizuho Securities

TIPRANKS
·
21 Mar

ADRs Close Lower; Adaptimmune Therapeutics PLC Declines 38%

Dow Jones
·
21 Mar

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading

MT Newswires Live
·
20 Mar

Adaptimmune Provides Q4 and Full Year 2024 Business Update

Newsfile
·
20 Mar

Adaptimmune Therapeutics PLC expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
18 Mar

Adaptimmune Therapeutics PLC expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
12 Mar